Results 151 to 160 of about 7,464 (222)

Preswitch Regimens Associated With Weight Gain Among Persons With HIV who Switch to Integrase Inhibitor-Containing Regimens. [PDF]

Open Forum Infect Dis
Cutshaw MK, Harding M, Davenport CA, Okeke NL.   +3 more
europepmc   +1 more source

DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain. [PDF]

Clin Infect Dis
Anderson D, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, Short WR.   +8 more
europepmc   +1 more source

Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV: A feasibility survey. [PDF]

HIV Med
Ballif M, Correia da Silva Saúde M, Haerry D, Stoeckle M, Schmid P, Braun D, Calmy A, Wandeler G, Surial B.   +8 more
europepmc   +1 more source

Post-Treatment HIV Control in a Married Couple. [PDF]

Infect Dis Clin Microbiol
Kaya A, Özdemir G, Yörük G, Durmaz Konyalı G, Kaya SY.   +4 more
europepmc   +1 more source

Comparison of treatment-emergent resistance-associated mutations and discontinuation due to adverse events among integrase strand transfer inhibitor-based single-tablet regimens and cabotegravir + rilpivirine for the treatment of virologically suppressed people with HIV: A systematic literature review and network meta-analysis. [PDF]

HIV Med
Rashid I, Unger NR, Willis C, Dhippayom T, Ramgopal M, Sherman EM, Yared N, Safran R, Swiatlo E, Weinberg AR, Navadeh S, Schmutz HW, Chaiyakunapruk N.   +12 more
europepmc   +1 more source

Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics. [PDF]

HIV Med
Adachi E, Minami R, Shirano M, Nakamura H, Fukushima K, Imahashi M, Sekiya R, Yoshino Y, Taniguchi T, J‐HIV RWD Collaborative Database Team.   +9 more
europepmc   +1 more source

Inhibition of OATP1B1/3 Rather Than UGT1A1 May Be the Major Cause of the Bilirubin Elevation After Atazanavir Administration. [PDF]

Clin Pharmacol Ther
Dong J, Sharma P, Emara R, Cheung D, Tang W, Zhou D, Boulton DW, Någård M, Park MS.   +8 more
europepmc   +1 more source

All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry. [PDF]

Clin Infect Dis
Giacomelli A, Capra N, Lolatto R, Gagliardini R, Clemente T, Calza L, Torti C, Lagi F, Fornabaio C, Marchetti G, Orofino G, Spagnuolo V, for PRESTIGIO Study Group .   +12 more
europepmc   +1 more source